TMCnet News
NEOGENOMICS INC FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 22, 2014, the board of directors (the "Board") of NeoGenomics, Inc. (the "Company") appointed Bruce Crowther to serve as a member of the Board effective immediately, filling a vacancy created by an increase in the size of the Board from six to seven. It is expected that Mr. Crowther will serve on the Board's audit committee and compliance committee. Mr. Crowther will receive quarterly fees of $11,250 paid quarterly in arrears for his service on the board of directors. Mr. Crowther will also receive fees for his service on the audit committee and on the compliance committee. Those fees will be $1,250 per committee per quarter and will be paid quarterly in arrears. Mr. Crowther will also receive a restricted stock grant of 1,500 shares which will vest over the next two (2) quarters for his service on the board of directors. Item 9.01. Financial Statements and Exhibits. (a) Not applicable (b) Not applicable (c) Not applicable (d) Exhibits. EXHIBIT DESCRIPTION LOCATION - 2 - -------------------------------------------------------------------------------- |